Skip to main content
OpenTrials
Completed

NCT Number: NCT06406036

A Validity and Reliability Study for Urdu Version of Rivermead Mobility Index in Stroke Patients

The aim of the study is to translate and cross-culturally adapt the Rivermead mobility index questionnaire into traditional Urdu language to investigate its psychometric properties (reliability & validity) for those patients who are confronting stroke.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ripah International University

Faisalabad, Punjab Province, 38000, Pakistan

About this study

As per preceding commendation, Rivermead Mobility Index will be translated into Urdu language from its English version and adapted culturally in Pakistan. Among Stroke population, Rivermead Mobility Index will be conducted in 50 patients recruited by convenience sampling technique under the pre-defined inclusion and exclusion criteria after signing consents forms. For testing inter-observer reliability and intra-observer reliability of Rivermead Mobility Index, Barthel Index and Functional Independence Measure will be administrated by two observers, on the same day, with a time interval of 2 hours between 1st and 2nd conduction. As for the 3rd conduction, it will be carried out after seven days by the first observer, for intra-observer assessment. Statistical Package of Social Sciences software version 24 has been used for the purpose of data entry and analysis. Internal consistency will be assessed by using an intra-class correlation coefficient. The Rivermead Mobility Index will be evaluated for content validity, construct validity, criterion validity and responsiveness.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male and female both genders
  • Adults between the ages of 18 and above
  • Stroke patients ( chronic)
  • Ability to provide informed consent

Exclusion criteria

  • Any musculoskeletal pathologies
  • Suffering from any cardiovascular pathologies
  • Any history of fracture
  • Any histories of infections
  • Any history of neurological disorders
  • Having any spinal deformity

Treatment and study plan

Primary outcomes

  1. Rivermead Mobility Index

    Time frame: 1st day

    The Rivermead Mobility index is a standardized assessment tool to investigate patients work and activity specific physical disability related to work. Rivermead Mobility Index scale have 15 items.

  2. Barthel Index

    Time frame: 1st day

    The Barthel Index is an ordinal scale that is used to assess performance in daily activities. A higher number reflects better capacity to operate independently upon hospital release.

  3. Functional Independence Measure

    Time frame: 1st day

    Functional Independence Measure instrument was designed for assessing responsive changes throughout the course of a complete inpatient medical rehabilitation programme. The instrument is used to determine a patient's level of impairment as well as any changes in their condition as a result of rehabilitation or medical treatment. Is an 18-item, seven-level, ordinal scale intended to be sensitive to changes over the course of a comprehensive inpatient medical rehabilitation program.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Reliability and Validity of Rivermead Mobility Index in Urdu Language Among Pakistani Stroke Population

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
May 9, 2024
Registry last updated
May 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.